Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from untreated Parkinson's disease patients

Neurology

Volumn 46, Issue 5, 1996, Pages 1343-1346

  Martin M A ^a   Molina, J A ^a   Jimenez Jimenez F J ^b,c   Benito Leon J ^a   Orti Pareja M ^b   Campos, Y ^a   Arenas, J ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^c C/ Corregidor Jose de Pasamonte   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; RESPIRATORY CHAIN ENZYME; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RATING SCALE; REFERENCE VALUE; RESPIRATORY CHAIN;

EID: 0029932989     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.46.5.1343     Document Type: Article

References (31)

1. Nicklas WJ, Vyas I, Heikkila RE. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 1985;36:2503-2508.
2. Vyas I, Heikkila RE, Nicklas WJ. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenyl-pyridinium. J Neurochem 1986;46:1501-1507.
3. Mizuno Y, Saitoh T, Sone N. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun 1987; 143:294-299.
4. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;1:1269.
5. Mizuno Y, Ohta S, Tanaka S, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989;163:1450-1455.
6. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 1990;54:823-827.
7. Schapira AH, Mann VM, Cooper JM, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 1990;55:2142-2145.
8. Mann V, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 1992;115: 333-342.
9. Janetzky B, Hauck S, Youdim MD, et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 1994;169:126-128.
10. Hattori N, Tanaka M, Ozawa T, Mizuno Y. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 1991;30:563-571.
11. Bindoff L, Birch-Machin M, Cartlidge NEF, Parker WD Jr, Turnbull DM. Mitochondrial function in Parkinson's disease. Lancet 1989;2:49.
12. Bindoff LA, Birch-Machin M, Cartlidge NEF, Parker WD Jr, Turnbull DM. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci 1991;104:203-208.
13. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1992;32:226-227.
14. Nakagawa-Hattori Y, Yoshino H, Kondo T, Mizuno Y, Horai S. Is Parkinson's disease a mitochondrial disease? J Neurol Sci 1992;107:29-33.
15. Anderson JJ, Bravi D, Ferrari TL, et al. No evidence for altered mitochondrial function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:477-480.
16. Cardellach F, Marti MJ, Fernández-Sola J, et al. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 1993;43:2258-2262.
17. DiDonato S, Zeviani M, Giovannini P, et al. Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 1993;43:2262-2268.
18. Blin O, Desnuelle C, Rascol O, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125:95-101.
19. Parker WD, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 1989;26:719-723.
20. Yoshino H, Nakagawa-Hattori Y, Kondo T, Mizuno Y. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1992;4:27-34.
21. Bravi D, Anderson JJ, Dagani F, et al. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Mov Disord 1992;7:228-231.
22. Krige D, Carrol MT, Cooper JM, Marsden CD, Schapira AH. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol 1992;32:782-788.
23. Benecke R, Strumper P, Weiss H. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 1993;116:1451-1463.
24. Barroso N, Campos Y, Huertas R, et al. Respiratory chain enzyme activities in lymphocytes from untreated patients with Parkinson disease. Clin Chem 1993;39:667-669.
25. Hughes AJ, Ben-Shlomo SE, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathological study. Neurology 1992;42:1142-1146.
26. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease. Florham Park, NJ: MacMillan 1987;2:153-163.
27. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:419-423.
28. Zheng X, Shoffner JM, Voljavec AS, Wallace DC. Evaluation of procedures for assaying oxidative phosphorylation enzyme activities in mitochondrial myopathy muscle biopsies. Biochim Biophys Acta 1990;101:1-10.
29. Moreu E, Molinero LM, Fernández E. R-Sigma. Base de datos bioestadística para un ordenador personal. Horus Hardware, Madrid, 1990.
30. Schapira AHV. Mitochondrial dysfunction in neurodegenerative disorders and aging. In: Schapira AHV, DiMauro S, eds. Mitochondrial disorders in neurology. Oxford: Butterworth-Heinemann, 1994:227-244.
31. Mizuno Y, Suzuki K, Ohta S. Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease. J Neurol Sci 1990;96:49-57.